Meta-analysis of Vitamin D RCTs for diagnosed depression - supplementation significantly outperformed placebo for symptoms of depression

Read Full Article

#VitaminD #DepressionResearch #RCTmetaanalysis

Depression isn’t just in the head: Scientists find altered genetic activity in white blood cells. This provides evidence that the biological footprints of depression extend well beyond the brain and into the immune system, offering a whole-body perspective on the condition.

Read Full Article

#DepressionResearch #Neuroimmune #MentalHealthScience

🧠 A study in Scientific Reports reveals that white blood cells in individuals with major depressive disorder show altered activity in genes typically linked to brain connections, suggesting depression's biological impact extends to the immune system.

🔬 Researchers at the University of São Paulo analyzed transcriptomic data from over 3,000 blood samples across the US, Germany, and France, comparing 1,864 individuals with major depressive disorder to 1,208 healthy individuals.

🧬 The analysis identified 1,383 altered genes in the defense cells of depressed patients, with 73 genes traditionally associated with synapses (like neurotransmitter transmission and neural connections) found to be active in immune and inflammatory pathways. 18 specific synapse-related genes consistently distinguished individuals with depression.

🔗 Seven specific synapse-related genes were found altered in both immune cells and brain regions involved in mood regulation. These genes are also linked to conditions like bipolar disorder, psychoses, anxiety, hypertension, arterial diseases, and psoriasis.

#DepressionResearch #MentalHealth #Immunology

Parkinson's medication shows promise in treating treatment-resistant depression that involves a reduced ability to feel joy, pleasure or motivation – known as anhedonia

Read Full Article

#ParkinsonsDisease #AnhedoniaTreatment #DepressionResearch

🧠 Researchers from Lund University have identified pramipexole, an existing Parkinson's disease drug, as a potential new add-on therapy for depression characterized by anhedonia (reduced ability to feel joy/pleasure).

🔬 In a randomized, double-blind, placebo-controlled trial of 82 participants, pramipexole showed a more pronounced improvement in anhedonia symptoms compared to placebo after nine weeks, with effects maintained during a six-month follow-up.

💡 Advanced brain imaging suggests pramipexole positively impacts the brain's reward system and increases physical activity, potentially by affecting the dopamine system.

✅ The study, published in Nature Medicine, found the treatment generally safe and well-tolerated, with efficacy and safety maintained over the six-month follow-up.

#DepressionResearch #Anhedonia #DrugRepurposing

🍎 A new study in the Proceedings of the National Academy of Sciences suggests people with depression have a higher baseline expectation for pleasure, making it harder to enjoy rewarding activities. A simple 3-minute smartphone game can detect this shift, potentially offering a quick assessment tool.

🎮 Researchers from NYU Langone Health found that adults with major depressive disorder had a ~50% higher reward expectation compared to healthy adults in a virtual foraging game. Their quitting points in the game strongly correlated with depression severity, and the game accurately separated patients from healthy adults.

🧠 In a second task, individuals with depression showed an inflexible response when adapting their reward expectations to changing environments, failing to return to their baseline bids, unlike healthy participants. This "reference point stickiness" may be a key mechanism in anhedonia.

#DepressionResearch #MentalHealth #TechForGood

Antidepressant found to be “unexpectedly effective” against brain tumours

Read Full Article

#DepressionResearch #BrainTumorTreatment #NeuroOncology

While tea consumption was not associated with depression and anxiety, coffee intake tends to lower depression symptoms, finds a new study from Iran (N=1,994).

Read Full Article

#CoffeeBenefits #MentalHealth #DepressionResearch

The link between vitamin intake and depression largely vanishes when factoring in lifestyle

Read Full Article

#MentalHealth #VitaminD #DepressionResearch

Acupuncture Seems to Rewire The Brain in Depression, Scans Reveal. When comparing the brain scans of people who had been given acupuncture treatments against those on antidepressants: acupuncture seemed to be rewiring specific brain regions.

Read Full Article

#Acupuncture #DepressionResearch #BrainImaging

🧠 Acupuncture May "Rewire" Brain Regions for Depression
A new study analyzing brain imaging data from 357 participants found that acupuncture treatment led to increased activity in brain regions linked to emotional control and reward processing, distinct from the effects of conventional antidepressants.

🧠 Different Pathways, Similar Goals
While antidepressants showed boosts in areas related to memory and visual processing, acupuncture appeared to target affective circuits involved in emotion regulation. The study suggests acupuncture may offer complementary mechanisms for treatment-resistant depression.

🧠 Promising Results for Symptom Relief
Compared to antidepressants alone, acupuncture was found to be more effective in reducing depression and anxiety scores in study volunteers, though most participants also received antidepressant medication.

#Acupuncture #DepressionResearch #MentalHealth

Randomised Trial Suggests High-Dose Vitamin B6 May Reduce Depressive Symptoms

Read Full Article

#VitaminB6 #DepressionResearch #MentalHealthScience

Depression stalls the formation of new neurons in the adult hippocampus, with the entire internal circuit experiencing molecular changes, signs of inflammation, and cellular stress among depressed patients

Read Full Article

#DepressionResearch #HippocampusNeurogenesis #Neuroinflammation

🧠 Columbia University researchers found that depression halts the creation of new brain cells in the hippocampus, a region crucial for memory and emotional response.

🔬 This study reveals molecular pathways controlling new neuron formation, potentially paving the way for new depression therapies.

💡 Impaired ability to form new neurons may hinder the brain's resilience to stress and adaptation, contributing to depression.

#DepressionResearch #Neuroscience #MentalHealth

Psilocybin reverses depressive behaviors and restores brain cell growth in stressed rats

Read Full Article

#Psychedelics #DepressionResearch #Neurogenesis

A large-scale global study reveals that depression is linked to a reduction in gray matter within the hippocampus, though these physical brain changes are found to be reversible, offering hope for targeted future treatments.

Read Full Article

#DepressionResearch #Hippocampus #Neuroplasticity

Measuring brain activity in 263 people with major depressive disorder, researchers identified five brain profiles for depression in which functional connectivity between brain regions differed

Read Full Article

#BrainImaging #DepressionResearch #FunctionalConnectivity

🧠 New research from the University of Helsinki has identified five distinct patterns of brain connectivity in individuals with depression, suggesting the condition may manifest differently across patients. The study used MEG to measure brain activity with millisecond precision, revealing contrasting patterns where some individuals show stronger, while others show weaker, functional connections between brain regions.

🧠 One identified group with particularly strong brain connectivity was linked to more severe substance abuse. Another group, exhibiting weaker connectivity, showed a greater prevalence of post-traumatic stress disorder (PTSD) symptoms. These findings could explain previous conflicting results in depression studies and support the idea that depression isn't a uniform biological disease.

🧠 While brain measurements are not yet used to select specific treatments, this research opens a pathway towards more personalized care. The long-term goal is to connect patients' symptoms directly to their brain function, potentially identifying suitable therapies faster and reducing trial-and-error approaches in the future.

#MentalHealth #BrainScience #DepressionResearch

A single dose of psilocybin eased depression within days, but its edge over placebo faded within a year. The effects appeared as early as the second day after dosing and lasted for more than three months, although by one year the difference between groups had faded.

Read Full Article

#PsilocybinTherapy #DepressionResearch #MentalHealthScience

💡 A new study identifies a 'circadian' subtype of depression, linked to perpetual jet lag, affecting about 25% of patients in a study of 11,380 individuals.

⏰ This subtype is characterized by symptoms that change with seasons, delayed sleep, social jet lag, an evening preference for sleep, and morning tiredness.

🧠 Participants with circadian depression experienced earlier onset, more severe symptoms like suicidality, weight gain, and higher genetic risk for neurodevelopmental and cardiovascular issues.

💊 Those with this subtype were less likely to respond to standard antidepressants and more prone to side effects, suggesting treatments like light therapy and melatonin could be more effective.

#DepressionResearch #MentalHealth #CircadianRhythm